» Articles » PMID: 26366410

Current Concept and Update of the Macrophage Plasticity Concept: Intracellular Mechanisms of Reprogramming and M3 Macrophage "Switch" Phenotype

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2015 Sep 15
PMID 26366410
Citations 125
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophages play a key role in immunity. In this review, we consider the traditional notion of macrophage plasticity, data that do not fit into existing concepts, and a hypothesis for existence of a new switch macrophage phenotype. Depending on the microenvironment, macrophages can reprogram their phenotype toward the proinflammatory M1 phenotype or toward the anti-inflammatory M2 phenotype. Macrophage reprogramming involves well-coordinated changes in activities of signalling and posttranslational mechanisms. Macrophage reprogramming is provided by JNK-, PI3K/Akt-, Notch-, JAK/STAT-, TGF-β-, TLR/NF-κB-, and hypoxia-dependent pathways. Posttranscriptional regulation is based on micro-mRNA. We have hypothesized that, in addition to the M1 and M2 phenotypes, an M3 switch phenotype exists. This switch phenotype responds to proinflammatory stimuli with reprogramming towards the anti-inflammatory M2 phenotype or, contrarily, it responds to anti-inflammatory stimuli with reprogramming towards the proinflammatory M1 phenotype. We have found signs of such a switch phenotype in lung diseases. Understanding the mechanisms of macrophage reprogramming will assist in the selection of new therapeutic targets for correction of impaired immunity.

Citing Articles

STAT signaling pathways in immune cells and their associated mechanisms in cancer pathogenesis.

Sohrabi S, Alipour S, Ghahramanipour Z, Masoumi J, Baradaran B Bioimpacts. 2025; 15:30030.

PMID: 39963570 PMC: 11830145. DOI: 10.34172/bi.30030.


Harnessing amino acid pathways to influence myeloid cell function in tumor immunity.

Pan J, Lin Y, Liu X, Zhang X, Liang T, Bai X Mol Med. 2025; 31(1):44.

PMID: 39905317 PMC: 11796060. DOI: 10.1186/s10020-025-01099-4.


Tumor microenvironment noise-induced polarization: the main challenge in macrophages' immunotherapy for cancer.

Sierra J, de Leon U, Padilla-Longoria P Mol Cell Biochem. 2025; .

PMID: 39827422 DOI: 10.1007/s11010-025-05205-2.


IL20RA Is the Key Factor Contributing to the Stronger Antioxidant Capacity of Rongchang Pig Sertoli Cells.

Zheng Q, Xiao L, An T, Zhang L, Long X, Wang Q Antioxidants (Basel). 2025; 13(12.

PMID: 39765872 PMC: 11727484. DOI: 10.3390/antiox13121545.


Macrophage Polarization in the Osteoarthritis Pathogenesis and Treatment.

Zou X, Xu H, Qian W Orthop Surg. 2024; 17(1):22-35.

PMID: 39638774 PMC: 11735378. DOI: 10.1111/os.14302.


References
1.
Motshwene P, Moncrieffe M, Grossmann J, Kao C, Ayaluru M, Sandercock A . An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem. 2009; 284(37):25404-11. PMC: 2757241. DOI: 10.1074/jbc.M109.022392. View

2.
Martinez-Nunez R, Louafi F, Sanchez-Elsner T . The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J Biol Chem. 2010; 286(3):1786-94. PMC: 3023473. DOI: 10.1074/jbc.M110.169367. View

3.
Sheedy F, Palsson-McDermott E, Hennessy E, Martin C, OLeary J, Ruan Q . Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2009; 11(2):141-7. DOI: 10.1038/ni.1828. View

4.
Driessler F, Venstrom K, Sabat R, Asadullah K, Schottelius A . Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin Exp Immunol. 2003; 135(1):64-73. PMC: 1808913. DOI: 10.1111/j.1365-2249.2004.02342.x. View

5.
Chen J, Olsen J, Ford S, Mirza S, Walker A, Murphy J . A new isoform of interleukin-3 receptor {alpha} with novel differentiation activity and high affinity binding mode. J Biol Chem. 2008; 284(9):5763-73. DOI: 10.1074/jbc.M808197200. View